130 related articles for article (PubMed ID: 6594927)
1. Phase II evaluation of aclacinomycin-A (NSC-208734) in adenocarcinoma of the kidney.
Decker DA; Drelichman A; Opipari MI; Al-Sarraf M
Am J Clin Oncol; 1984 Oct; 7(5):527-8. PubMed ID: 6594927
[No Abstract] [Full Text] [Related]
2. Phase II evaluation of aclarubicin in advanced breast cancer: a Southeastern Cancer Study Group trial.
Gockerman JP; Raney M; Logan T
Cancer Treat Rep; 1985 Sep; 69(9):1029-30. PubMed ID: 3861247
[No Abstract] [Full Text] [Related]
3. Phase II evaluation of aclarubicin in lung cancer: a Southeastern Cancer Study Group Trial.
Kramer BS; Birch R; Gockerman JP; Greco A; Prestridge K
Cancer Treat Rep; 1986 Jun; 70(6):803-4. PubMed ID: 3015404
[No Abstract] [Full Text] [Related]
4. Phase II evaluation of aclacinomycin-A in advanced ovarian carcinoma.
Martino S; Decker DA; Hynes HE; Kresge CL
Invest New Drugs; 1987 Dec; 5(4):373-4. PubMed ID: 3481362
[TBL] [Abstract][Full Text] [Related]
5. A phase II study of aclacinomycin A in acute leukemia in adults.
Yamada K; Nakamura T; Tsuruo T; Kitahara T; Maekawa T; Uzaka Y; Kurita S; Masaoka T; Takaku F; Hirota Y; Amaki I; Osamura S; Ito M; Nakano N; Oguro M; Inagaki J; Onozawa K
Cancer Treat Rev; 1980 Dec; 7(4):177-82. PubMed ID: 6938305
[No Abstract] [Full Text] [Related]
6. Phase II trial of aclacinomycin in acute leukemia and lymphosarcoma.
Mathé G; Gil MA; Delgado M; Bayssas M; Gouveia J; Ribaud P; Machover D; Misset JL; de Vassal F; Schwarzenberg L; Jasmin C; Hayat M
Recent Results Cancer Res; 1980; 74():217-22. PubMed ID: 6893752
[No Abstract] [Full Text] [Related]
7. Current status of Japanese studies with the new anthracycline antibiotic aclacinomycin A.
Oki T; Takeuchi T; Oka S; Umezawa H
Recent Results Cancer Res; 1980; 74():207-16. PubMed ID: 7003659
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of aclarubicin in epidermoid carcinoma of the head and neck.
Carugati AA; Olivari AJ; Campos DM; Pradier R; Woolley PV
Cancer Treat Rep; 1986 Jun; 70(6):799-800. PubMed ID: 3524828
[No Abstract] [Full Text] [Related]
9. Aclacinomycin. Phase II evaluation in advanced squamous carcinoma of the head and neck.
Kish JA; Al-Sarraf M
Am J Clin Oncol; 1984 Oct; 7(5):535-7. PubMed ID: 6507374
[TBL] [Abstract][Full Text] [Related]
10. Aclarubicin in the treatment of relapsed or resistant acute myelogenous leukaemia: a phase II trial.
Evensen SA; Wisløff F; Müller E; Talstad I; Waage A; Johansen L
Eur J Haematol Suppl; 1987; 47():43-7. PubMed ID: 3471524
[No Abstract] [Full Text] [Related]
11. Phase I-II study of aclarubicin for treatment of acute myeloid leukaemia.
Machover D; Gastiaburu J; Delgado M; Goldschmidt E; Hulhoven R; Benavides M; Lotz JP; Misset JL; de Vassal F; Tapiero H
Eur J Haematol Suppl; 1987; 47():33-42. PubMed ID: 3471523
[No Abstract] [Full Text] [Related]
12. Aclacinomycin A. Phase II evaluation in advanced soft tissue sarcoma.
Pazdur R; Samson MK; Baker LH
Am J Clin Oncol; 1987 Jun; 10(3):237-9. PubMed ID: 3473924
[TBL] [Abstract][Full Text] [Related]
13. Aclacinomycin A. Phase II evaluation in bronchogenic squamous-cell carcinoma.
Pazdur R; Samson MK; Baker LH
Am J Clin Oncol; 1987 Jun; 10(3):234-6. PubMed ID: 3473923
[TBL] [Abstract][Full Text] [Related]
14. Aclarubicin (aclacinomycin A) in the treatment of relapsing acute leukaemias.
Mitrou PS; Kuse R; Anger H; Herrmann R; Bonfert B; Pralle H; Thiel E; Westerhausen M; Mainzer K; Bartels H
Eur J Cancer Clin Oncol; 1985 Aug; 21(8):919-23. PubMed ID: 3862584
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of aclarubicin in patients with breast cancer previously untreated with adriamycin.
Kerpel-Fronius S; Gyergyay F; Hindy I; Decker A; Sawinsky I; Mechl Z; Nekulova M; Kolariĉ K; Tomek R; Röthig J
Eur J Haematol Suppl; 1987; 47():67-9. PubMed ID: 3471527
[No Abstract] [Full Text] [Related]
16. Phase II evaluation of aclacinomycin-A in patients with adenocarcinoma and large cell carcinoma of the lung.
Tapazoglou E; Haas CD; Samson MK; Baker LH; Pazdur R
Am J Clin Oncol; 1985 Aug; 8(4):298-301. PubMed ID: 3002165
[TBL] [Abstract][Full Text] [Related]
17. Clinical study of aclacinomycin A.
Ogawa M; Inagaki J; Horikoshi N; Inoue K; Chinen T; Ueoka H; Nagura E
Cancer Treat Rep; 1979 May; 63(5):931-4. PubMed ID: 455335
[TBL] [Abstract][Full Text] [Related]
18. Phase II evaluation of aclarubicin in refractory multiple myeloma: a Southeastern Cancer Study Group Trial.
Gockerman JP; Silberman H; Bartolucci AA
Cancer Treat Rep; 1987; 71(7-8):773-4. PubMed ID: 3300970
[No Abstract] [Full Text] [Related]
19. Phase I-II trial of aclacinomycin A given in a four-consecutive-day schedule to patients with solid tumours. A South-East European Oncology Group (SEEOG) Study.
Kerpel-Fronius S; Gyergyay F; Hindy I; Decker A; Sawinsky I; Fäller K; Mechl Z; Nekulova M; Kolaric K; Tomek R
Oncology; 1987; 44(3):159-63. PubMed ID: 3474571
[TBL] [Abstract][Full Text] [Related]
20. A phase II trial of aclacinomycin-A in advanced squamous cell carcinoma of the head and neck.
Eckenrode JL; Wheeler RH; Forastiere AA
Invest New Drugs; 1985; 3(4):389-92. PubMed ID: 3866756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
